Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

223 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
European S2k guidelines for hidradenitis suppurativa/acne inversa part 2: Treatment.
Zouboulis CC, Bechara FG, Benhadou F, Bettoli V, Bukvić Mokos Z, Del Marmol V, Dolenc-Voljč M, Giamarellos-Bourboulis EJ, Grimstad Ø, Guillem P, Horváth B, Hunger RE, Ingram JR, Ioannidis D, Just E, Kemény L, Kirby B, Liakou AI, McGrath BM, Marzano AV, Matusiak Ł, Molina-Leyva A, Nassif A, Podda M, Prens EP, Prignano F, Raynal H, Romanelli M, Saunte DML, Szegedi A, Szepietowski JC, Tzellos T, Valiukevičienė S, van der Zee HH, van Straalen KR, Villumsen B, Jemec GBE. Zouboulis CC, et al. Among authors: prens ep. J Eur Acad Dermatol Venereol. 2024 Dec 19. doi: 10.1111/jdv.20472. Online ahead of print. J Eur Acad Dermatol Venereol. 2024. PMID: 39699926
Association of inflammatory skin biomarkers with clinical response in RGRN-305-treated patients with hidradenitis suppurativa.
Ben Abdallah H, Bregnhøj A, Emmanuel T, Bertelsen T, Dudink K, van Straalen KR, Kubacz M, Ghatnekar G, Prens EP, Iversen L, Johansen C. Ben Abdallah H, et al. Among authors: prens ep. J Eur Acad Dermatol Venereol. 2024 Dec 2. doi: 10.1111/jdv.20468. Online ahead of print. J Eur Acad Dermatol Venereol. 2024. PMID: 39620484 No abstract available.
Needle-free jet injector treatment with bleomycin is efficacious in patients with severe keloids: a randomized, double-blind, placebo-controlled trial.
Bekkers VZ, Zdunczyk KM, Bik L, Ten Voorde W, Aarts P, Oerlemans F, Bohoslavsky R, Haedersdal M, Prens EP, Rissmann R, van Doorn MBA. Bekkers VZ, et al. Among authors: prens ep. Clin Exp Dermatol. 2024 Nov 22;49(12):1668-1675. doi: 10.1093/ced/llae254. Clin Exp Dermatol. 2024. PMID: 39030712 Clinical Trial.
Proof-of-concept study exploring the effect of spesolimab in patients with moderate-to-severe hidradenitis suppurativa: a randomized double-blind placebo-controlled clinical trial.
Alavi A, Prens EP, Kimball AB, Frew JW, Krueger JG, Mukhopadhyay S, Gao H, Ranganathan U, Ivanoff NB, Hernandez Daly AC, Zouboulis CC. Alavi A, et al. Among authors: prens ep. Br J Dermatol. 2024 Sep 18;191(4):508-518. doi: 10.1093/bjd/ljae144. Br J Dermatol. 2024. PMID: 38576350 Clinical Trial.
International Hidradenitis Suppurativa Severity Scoring System (IHS4) as a holistic measure of hidradenitis suppurativa disease severity compared with Hurley staging: A post hoc analysis of the SUNRISE and SUNSHINE phase 3 trials of secukinumab.
Zouboulis CC, Prens EP, Sayed CJ, Molina-Leyva A, Bettoli V, Romanelli M, Szepietowski JC, Martinez AL, Kasparek T, Lobach I, Wozniak MB, Ortmann CE, Thomas N, Bachhuber T, Ravichandran S, Tzellos T. Zouboulis CC, et al. Among authors: prens ep. J Eur Acad Dermatol Venereol. 2024 Jun;38(6):e496-e499. doi: 10.1111/jdv.19681. Epub 2023 Dec 6. J Eur Acad Dermatol Venereol. 2024. PMID: 38058224 Clinical Trial. No abstract available.
223 results